Weight-Related Quality of Life, Health Utility, Psychological Well-Being, and Satisfaction With Exenatide Once Weekly Compared With Sitagliptin or Pioglitazone After 26 Weeks of Treatment

OBJECTIVE: To assess change in patient-reported outcomes in subjects with type 2 diabetes treated with exenatide once weekly compared with those treated with sitagliptin or pioglitazone. RESEARCH DESIGN AND METHODS: In this 26-week randomized, multicenter, double-dummy study, 491 subjects received 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Best, Jennie H., Rubin, Richard R., Peyrot, Mark, Li, Yan, Yan, Ping, Malloy, Jaret, Garrison, Louis P.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024340/
https://www.ncbi.nlm.nih.gov/pubmed/21270189
http://dx.doi.org/10.2337/dc10-1119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024340/
https://www.ncbi.nlm.nih.gov/pubmed/21270189
http://dx.doi.org/10.2337/dc10-1119

Ejemplares similares